Trial · NCT04469465
Participant flow26
How many started, completed or left each group, period by period.
1 to 20 of 26
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period 1 (TP1) | STARTED | Danicopan-Danicopan | 57 | |
| Treatment Period 1 (TP1) | STARTED | Placebo-Danicopan | 29 | |
| Treatment Period 1 (TP1) | Received at Least 1 Dose of Study Drug | Danicopan-Danicopan | 57 | |
| Treatment Period 1 (TP1) | Received at Least 1 Dose of Study Drug | Placebo-Danicopan | 29 | |
| Treatment Period 1 (TP1) | Interim Efficacy Analysis Set | Danicopan-Danicopan | 42 | |
| Treatment Period 1 (TP1) | Interim Efficacy Analysis Set | Placebo-Danicopan | 21 | |
| Treatment Period 1 (TP1) | COMPLETED | Danicopan-Danicopan | 55 | |
| Treatment Period 1 (TP1) | COMPLETED | Placebo-Danicopan | 27 | |
| Treatment Period 1 (TP1) | NOT COMPLETED | Danicopan-Danicopan | 2 | |
| Treatment Period 1 (TP1) | NOT COMPLETED | Placebo-Danicopan | 2 | |
| Treatment Period 2 (TP2) | STARTED | Danicopan-Danicopan | 55 | |
| Treatment Period 2 (TP2) | STARTED | Placebo-Danicopan | 27 | |
| Treatment Period 2 (TP2) | Received at Least 1 Dose of Study Drug | Danicopan-Danicopan | 55 | |
| Treatment Period 2 (TP2) | Received at Least 1 Dose of Study Drug | Placebo-Danicopan | 27 | |
| Treatment Period 2 (TP2) | COMPLETED | Danicopan-Danicopan | 54 | |
| Treatment Period 2 (TP2) | COMPLETED | Placebo-Danicopan | 26 | |
| Treatment Period 2 (TP2) | NOT COMPLETED | Danicopan-Danicopan | 1 | |
| Treatment Period 2 (TP2) | NOT COMPLETED | Placebo-Danicopan | 1 | |
| Long-Term Extension (LTE) | STARTED | Danicopan-Danicopan | 54 | |
| Long-Term Extension (LTE) | STARTED | Placebo-Danicopan | 26 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04469465/flow